BDBM38826 3-[2-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-2-oxoethyl]-1-ethylquinazoline-2,4(1H,3H)-dione::3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-keto-ethyl]-1-ethyl-quinazoline-2,4-quinone::3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxidanylidene-ethyl]-1-ethyl-quinazoline-2,4-dione::3-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxoethyl]-1-ethylquinazoline-2,4-dione::MLS000047030::SMR000033041::cid_3244712

SMILES CCn1c2ccccc2c(=O)n(CC(=O)N2CCC3(CC2)OCCO3)c1=O

InChI Key InChIKey=ZNOFSARQDMJIFN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 38826   

TargetM-phase inducer phosphatase 2(Human)
University of Pittsburgh

Curated by PubChem BioAssay
LigandPNGBDBM38826(cid_3244712 | 3-[2-(1,4-dioxa-8-azaspiro[4.5]dec-8...)
Affinity DataIC50: 5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2011
Entry Details
PCBioAssay